The rationale of probiotics in urogenital female healthcare and after pregnancy
Turku Microbiome Biobank: Could microbiome analyses & microbial-based prevention & therapy be part of the future of personalized medicine?
The Microbiome of the Female Reproductive Tract, Pregnancy and Women’s Reproductive Health
Immune responses to bacterial antigens and association with colorectal cancer risk in a large European cohort study
Mechanisms involved in the prevention of type I diabetes onset by Lactobacillus johnsonii N6.2
Environmental mycobacteria as next-generation immunobiotics for mental health
Modulating the appetite through the probiotic strain Hafnia alvei HA4597
Vaginal Microbiota Management and Impact on Women’s Health
Webinar: The potential of developing a new generation of microbiome therapies
Cannabinoids and the Microbiome: How the Tone Impacts Clinical Trial Strategy
ProbioSatys®, Naturally Modulating the Appetite through the Microbiome
Claim Development and Substantiation: Legal and Regulatory Considerations
Microbiome Therapeutics: Next Generation Prebiotic
FMT-based discovery: from platform to product
Understanding the role of the gut microbiome in NAFLD
Lysates vs Live Probiotics in Skin Care
Increasing plant protein digestion in an in vitro model
Advanced NGS solutions for microbiota research
Identification and Therapeutic Application of Rationally Selected, Novel Components of the Human Skin Microbiome
Ammonia Oxidising Bacteria: A Live Topical Therapeutic
From Integrated Multi-Omics to Causality in Microbiome Research
Control of Appetite Through the Microbiome
Mast Cells, Microbes and the Gut-Brain Axis
Identifying Blood Microbiota: A Convenient Surrogate Biomarker of Gut Microbiota Dysbiosis
The Future of Gut Microbiome Analysis
Recent Developments in the Probiotic Research and Market
Gut feeling: function based microbiome research
Reports and Investor Spreadsheets
Translating Microbiome Futures
The Updated List Of Microbiome Companies And Investors
The Big List Of Prebiotics/Probiotics Companies And Investors
The Big List of Microbiome Companies and Investors
How to get Funding for your Human Microbiome Startup
Poster Presentations
Multiple approaches to innovate microbiome knowledge and rebalancing
Translational pig model for microbiota management and its effects on intestinal health
Oral Multispecies Probiotic Supplement to Colonise Vaginal Epithelium, Improve Bacterial Vaginosis Symptoms and Restore Vaginal Microbiota
PhD project: Potential Probiotics from Gut Microbiota
Computing Metabolic Routes in the Human Microbiome
Flow Cytometry: A New Method to Enumerate Probiotic Spores
Divergent meta-transcriptional response of the upper and lower jaw dental plaque biofilm after sucrose exposure
All-in-One Microbiome Analysis with OmicsBox
The Greenhouse Pharmacy: Cultivating plants for Cosmeceuticals
Presentation Slides
The Prebiotic Opportunity: Consumer Perceptions and State of the Market
Hafnia alvei HA4597, pioneer next-generation probiotic, precision probiotic and its postbiotic ClpB, supporting weight loss through the molecular mimicry of a satiety hormone
The gut-bone axis: Bifidobacterium lactis strain BL-99 reduces intestinalinflammation and osteoporosis
Human milk oligosaccharides in breast milk: personalized nutrition, naturally? What does it mean for the practice?
A Nutritional ‘Immune Fertiliser’ that Stops the Flu
Generating meaningful results: best practices, standards, and tools for microbiome research
Hafnia alvei HA4597® for the regulation of appetite
Microbiome-based biomarkers to address unmet patient needs in IBD
May the Fiber Be with You: Gut Microbiomes from a remote Amazon village to the undergraduate lab
An engineered probiotic specifically targeting a gastrointestinal pathogenic bacterium
Expediting Biomarker Discovery Using Precision Taxonomy
Microbiome-based biomarkers, to support the development and market access of microbiome modulating drugs
Leveraging the microbiome to address skin health and treat skin disease
Time to consider Archaea as pharmabiotics for cardiovascular disease and more
The BioCollective and Probiotic Development
The use of ‘live’ beneficial lactobacilli to treat skin conditions
Health Promoting Properties Encoded Within Fermented Food Microbiota
Scalp Microbiome – The next big shift in beauty
Insights from synthetic gut communities
Cannabinoids and the Microbiome: How the Tone Impacts Clinical Trial Strategy
The collaborative efforts and research directions of European microbiome funding
NIZO: Helping You Create Microbiome Modulators
Understanding the role of the gut microbiome in nonalcoholic fatty liver disease
Lysates vs Live Probiotic cultures in skincare – what are the benefits and differences?
The Asian gut microbiome, a new therapeutics discovery opportunity
Postbiotics, why we believe they are probiotics 2.0
Mechanisms involved in the prevention of type I diabetes onset by Lactobacillus johnsonii N6.2
Temporal Changes in the Facial Skin Microbiome – A One-Year Longitudinal Study in Normal Healthy Men and Women
MAPPAC (Microbiology Appendicitis Acuta) trial: Acute appendicitis and microbiota –etiology and effects of the antimicrobial treatment
Claim Development and Substantiation: Legal and Regulatory Considerations
Selecting Critical Attributes During Digestive Health Product Development
Protecting Inventions in the Microbiome Space: Challenges and Strategies
Postbiotic Metabolites: The New Frontier in Microbiome Science
Collision of Industries: A Case Study of a GI Microbiome Modulator
Shared responsibility for Industry, Regulators and Press: what to do to get the consumer correctly informed on probiotics?
Development of microbiome-derived products for cardiometabolic indications
MicrobiomeSupport – a global initiative to coordinate microbiome research and innovation activities in the food system
Formulation, Scientific Substantiation and Labeling of Probiotics Products
Transition of microbiota analysis from research tool to clinical utility
Ingestion of probiotic Bacillus coagulans GBI-30, 6086 increases plant protein digestion in a dynamic, computer-controlled in vitro model of the small intestine (TIM-1)
MatriSys Bioscience – new developments
We are using cookies to give you the best experience on our site. By continuing to use our website you are agreeing to our use of cookies.AcceptRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
